Mass Tort Institute Mass Tort Talks

Mass Tort Talks featuring Susan Barfield

https://youtu.be/FmwfBTU4jXw Presented by The Mass Tort Institute Hi, my name is Susan and I am the founder and CEO of Case Works. My goal today …

Read More
covid

COVID-19’s Impact on the Mass Tort Landscape

COVID-19’s Impact on the Mass Tort Landscape The mass tort landscape is reaching a new peak while COVID-19 outbreaks and the Delta variant continue to …

Read More

The Biggest Challenges for Mass Tort Firms

Mass tort litigation firms stand to recover large settlement amounts for their clients in mass tort litigation proceedings.

Read More

Advantages of Outsourcing Client Case Management

Whether you need to outsource core functions, simple business functions, or just looking for cost savings, outsourcing business processes and operations can benefit all types of law firms.

Read More

Zantac Litigation Update: Latest Developments

The mass action litigation against the makers of the popular antacid medication Zantac is still in the early stages. On April 1, 2020, the U.S. Food and Drug Administration (FDA) issued an immediate market withdrawal request of all ranitidine-based medications including Zantac.

Read More

PFAS Victims Reach Two Major Settlement Deals

DuPont and several related companies have committed $4 billion to cover liabilities stemming from their past use of toxic “forever chemicals” such as PFAS and PFOA. The group of companies also agreed to pay $83 million to settle multidistrict litigation in Ohio to compensate victims harmed by the chemicals.

Read More

$8.3 Billion Purdue Opioid Settlement Update

In mid-November 2020, the U.S. Bankruptcy Court for the Southern District of New York approved a federal settlement agreement valued at $8.3 billion between Purdue Pharma and the Department of Justice (DOJ). As part of the deal, Purdue will plead guilty to 3 felony criminal counts of defrauding the United States.

Read More

Judge Dismisses Zantac Claims on Federal Preemption

In two recent rulings, U.S. District Court Judge Robin L Rosenberg dismissed a host of claims against Zantac defendants based on federal pre-emption. In short, preemption is a doctrine that can shield drug manufacturers from liability in certain cases where they follow the FDA requirements for an approved drug or medication.

Read More
Elmiron

New MDL Formed for Elmiron Litigation

At its last meeting of 2020, the Judicial Panel on Multidistrict Litigation (JPML) decided to create a new Multidistrict Litigation (MDL) to hear claims filed …

Read More

Allergan’s Game of Hide & Seek with the FDA

According to complaints filed by plaintiff’s attorneys, Allergan’s misconduct includes using a loophole in the FDAs reporting requirements to hide instances of serious injuries associated …

Read More

ParaGard MDL Created in Northern District of Georgia

In a much-anticipated decision, the Judicial Panel on Multidistrict Litigation (JPML) ruled on December 16, 2020 to centralize ParaGard IUD claims against Teva Pharmaceuticals in …

Read More

Latest Defendant Shenanigans in the Valsartan Litigation

Plaintiffs injured by contaminated valsartan are fighting attempts by Walgreens, CVS and Rite Aid to avoid claims they misrepresented a generic high blood pressure drug …

Read More

Court Rules Against “Lifesaving Device” Claims for Hernia Mesh

In a recent court ruling C.R. Bard was told they cannot argue their hernia mesh implant is a “lifesaving device” in the upcoming bellwether trial …

Read More

Bayer’s Essure Defense Strategy to Avoid Liability

Two years after Bayer A.G. halted sales of Essure in the United States, the company announced it would settle outstanding legal claims for $1.6 billion. …

Read More

Truvada Generics Hit the Market

After years of raking in billions of dollars from its Tenofovir Disoproxil Fumarate (TDF) drug monopoly, Gilead Sciences will have to face competition from the …

Read More

J&J Loses Bid to Appeal $2.1 Billion Talc Powder Verdict

Last week, the Missouri Supreme Court shot down Johnson & Johnson’s bid to appeal a $2.1 billion jury verdict in favor of women who blamed …

Read More

FDA Recalls Metformin After Finding Known Carcinogen

The FDA continues to recommend manufacturer recalls of the popular diabetes medication metformin after testing shows the presence of a known carcinogen, N-nitrosodimethylamine, more commonly …

Read More

$1.6 Billion Essure Settlement Announced

On August 20, 2020, Bayer A.G. announced it would pay $1.6 billion to settle Essure claims from women who have been injured by the defective …

Read More

New FDA Label Suggested for Breast Implants

On September 29, 2020, the U.S. Food and Drug Administration (FDA) released final labeling recommendations aimed at improving patients’ understanding of the risk associated with …

Read More

How Safe is Your Drinking Water?

What is PFAS and Why is it so Dangerous? Simply put, PFAS is class of more than 4,000 different chemicals and turns up in many …

Read More